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The Clinician Scientist -An endangered species?
Annual Oration - Royal Victoria Hospital - 5th October 1995
Ingrid V Allen
I am grateful to my fellow members of staff for
doing methehonourofasking metogivethis, the
168th, annual oration, buthonourandpleasure of
course are not synonymous, andthis occasion for
me, while a great honour, is a qualified pleasure
-probablyfortheaudiencetoo,sooursympathies
are mutual. There is however one aspect which is
pleasurable, andthatistobeintroducedasa lady.
Since my appointment to the staffofthis hospital
I have been described by various epithets, all
justified but not all entirely complimentary; it is
therefore a singular honour to be described not
only as a lady but as "the first lady".
In a way it shows how far medicine has come
fromthoseearlydays, forexamplehereinBelfast,
when to quote from J C Beckett and Theodore
Moody's History of Queen's:-1 "In April 1891,
nine women medical students and twenty three
men-(medical students werealways intelligent),
petitioned President Hamilton thus:- We, the
undersigned, beg to draw attention to the
following facts with regard to the position of
women studying at Queen's College: Women,
though allowed to attend the lectures at the
aforesaid College, do nothold the legal status of
students. They may enterfor examinations, but
are not eligible for any of the prizes or
scholarships. As this position is clearly an
anomalous one, we think that in the interests of
justicesomechangeshouldbemade. Wetherefore
humbly petition you to take such steps as shall
seem to you advisable to obtain for women
studying at Queen's College a position equal to
thatwhich theynow holdin theRoyal University,
in which all degrees, honours exhibitions,
scholarships and prizes are open to students of
either sex. "
Beckett and Moody go on to say in the patrician
style of the professional historian:- "Hamilton
not only supported this, but to allay any doubts
about the ability of women to profit by higher
education he quoted the opinion of Professor
Redfern: 'The continued successes offemales in
the intermediate and various university
examinations for some years past forbid any
further speculations as to their chances in
intellectualcompetitionswithmen. Noonewould
dare at present to suggest that they will not be
able toholdtheirown in intellectualstruggles on
any subject, ifthey have equal advantages with
men" - and the rest of course is history.
The first woman to graduate in medicine at
Queen's, Dr Elizabeth Bell, did so in 1893, and
today I look across at our student body, a total
reflectionofthegendercompositionoftheyoung
adult population. You will notice my use of the
politically correctword 'gender' ratherthan 'sex'
- I wonder whether today Sir William Osler
wouldgetawaywithhis light-heartedquipthatin
medicine there are notjust two sexes but three -
men, women andwomenphysicians. Iwouldadd
afourth,malesurgeons,andsay"longlivehumour
and sex, two very important components oflife".
The serious point is thattoday, atlast, the gifts of
men and women are fully used in the cause of
medicine.
This of course is our students' day and our
Chairman has already welcomed you and given
you aflavourofthecultureandphilosophyofthis
great hospital and it is as an extension of those
ideas that I have chosen, as the subject of my
Oration, TheClinician Scientist-anEndangered
Species? Indefining clinical science andtherole
ofthe clinician scientist, the cardinal issue is our
acceptance that medicine is a science in its own
right. That is not to say that the practice of
medicine for the majority demands the
establishment of new facts or principles, but
rather that in the practice of medicine the
opportunity exists to advance knowledge, and
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this opportunity can only be exploited fully by
theapplicationofbasicsciencetothemoreapplied
science ofclinical practice. In accepting this fact
we should not think too narrowly as to what the
relevant basic sciences are - they cover a wide
spectrum, from the most fundamental and
structural, for example physics and chemistry,
through to cognitive psychology, social science,
engineering and economics.
Thus it has been stated that "Medical History
involvessocialandeconomic, aswellasbiological
content, andpresents oneofthe central themes in
human experiences".2
In all cultures, although the practice ofmedicine
has involved elements of the religious and the
intuitive, the overwhelming element has been
and is scientific.
If primitive man could use medicinal plants for
their specific antifebrile, laxative, emetic,
antispasmodic, diuretic, analgesic, sedative,
stimulatory and hallucinatory effects (Lyons,
HistoryofMedicine),3 withwhatgreatercertainty
can we in this age affirm the Hippocratic view of
medicine as a science in its own right, and with
Hippocrates say"thereisnosciencewhichhas no
basis in fact".4
WetoowouldendorsetheviewofFlexner(1910),5
expressed over 2000 years afterHippocrates, but
not deviating from the Hippocratic logic. In
Flexner'sidealmedicaleducation, twoprinciples
operate - first that the basic sciences, (that is
chemistry, physics and biology) provide the
intellectual foundation ofmodern medicine, and
secondly that the scientific method should be
applied to the practice of medicine as well as to
research. "It makes no difference to science",
said Flexner, "whether usable data be obtained
from a slide beneath a microscope or from a sick
man stretched out on a bed".
Flexner's seminal report was based on the
nineteenth century successes of European,
including British medicine, and laid the
framework for twentieth century successes in
biomedical research in the United States.
Iftherefore we accept medicine as a science, and
scientific endeavour the basis of advance, then
the medical scientist as an individual is of
enormous importance. A clinician certainly, but
one whose major role is to establish new facts,
new principles and new methods. Of course,
throughouthistory suchindividuals haveexisted.
Among the most famous for example is Joseph
Lister, who used and acknowledged the work of
Pasteur in his studies of wound sepis. This
illustration indicates precisely the role of the
clinician scientist, as do many less famous but
nevertheless important local examples.
I will quote one - the late Dr Lewis Hurwitz,6
when working here in Belfast with Professor
Molly McGeown in the very early days of renal
transplantation, used an interdisciplinary
approach involving clinical neurology,
biochemistry, transplantation technology and
neurophysiology to show the beneficial effect of
renal transplantation upon the peripheral
neuropathy of chronic renal failure.
The achievements of the scientific approach are
legion, and the need for dedicated clinician
scientists has become increasingly great as the
biological revolution has taken off and its
translation into clinical practice becomes a
realistic goal. It is the clinical investigator who
servesthisfunctionandisthevitalbridgebetween
basic science and improvements in health care. It
is thereforeparadoxical, that many now consider
thespeciesofclinicianscientisttobeendangered.
The most extreme and pessimistic view was
expressed by Professor Gordon Gill at the
University of California at San Diego, in his
essay on 'The End of the Physician Scientist'.'
He describes how from the 1960s to the 1980s
biomedicalresearchenterpriseintheUnitedStates
passed largely out of the realm of clinicians and
into the realm of non-medically qualified
postdoctoral scientists. He states that similar
changes occurredinEurope, includingtheUnited
Kingdom, in the 1990s. "Like it or not" he
concludes "the separation of Physicians and
Scientists is well advanced" - "partial attention
toeitherscienceormedicineisnolongerenough".
Many disagree with this view and I hold myself
among them. I would emphasise the diversity of
medicalresearch, andrecognisethatsomewillbe
done by medically qualified scientists and some
by other scientists, and that these two are
complementary. Molecular biology will enrich
clinical medicine enormously, but it is only the
starting point to an understanding ofphenotype,
andepidemiology willcontinue toholdthekey to
preventive medicine.
Theparticulardifficulty fortheclinician scientist
is in gaining sufficient knowledge ofthe relevant
basic sciences, while retaining and developing
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essential clinical skills. Many would agree with
Judah Folkman who has recently succinctly
described the negative attitudes that are likely to
surroundthebuddingclinicalinvestigatoroftoday
whenhestatesthat: "Theindividualwhoattempts
to combine investigation with a clinical career
travels the toughestroad, however fruitful itmay
be in the end. His counterpart in basic science
thinks he is a dilettante researcher, his clinical
colleagues think he is unsafe, and his mother-in-
law says, -He's 35 years old and stillworking on
rats. When will he be a real doctor?"8
However in contemplating the potential adverse
factorsinfluencingtheclinicianscientist, Iwould
like to quote fromJohnGardnerand would agree
that in fact "we are faced with a series of great
opportunities brilliantly disguised as insoluble
problems".9
No one wants clinical science to fail and it is
therefore essential that the necessary changes in
medical training, in thepractice ofmedicine, and
in the allocation of resources are managed
correctly. Several factors operate including the
exponential growth in science, greater
specialisation in science and medicine,
competition forresources and the perhaps timely
death of the renaissance amateur clinician
scientist.
Medicine faces some specific and indeed unique
challenges, in that the emerging biological
principles andthe associatedtechnology apply to
the whole of medicine, while medicine itself is
still held in the stranglehold of a systematised
anatomical framework. These intellectual and
logistical challenges are only now being
considered by medical schools and teaching
hospitals throughout the world, and as yet no
pattern ofplanning has emerged which gives us
confidence in looking to the future.
At the same time as we face these issues, we are
reorganising, again world wide, the medical
curriculum, postgraduate medical training and
health caredelivery, the latterdictatedby market
forces,whileunderlyingethicaldilemmasremain.
At times like this we would endorse the words of
Gaius Petronius, Arbiter, Proconsul at Bithynia
in AD 65:-10 "We trainedhardbut itseemedthat
every time we were beginning toform teams we
would be reorganized. Iwas to learn later in life
that we tend to meet every situation in life by
reorganizing, and a wonderful method it can be
for creating the illusion of progress while
producing confusion, inefficiency and
demoralization".
So letus considerhow the clinician scientist may
be affected by all ofthese changes. First ofall in
the training of tomorrow's doctors. The
curriculum has to be a compromise, balancing
thepursuitofknowledgeforits own sakewiththe
requisition of practical skills essential for safe
practice. ThesolutionputforwardbytheGeneral
Medical Council is a reasonable compromise,
and allows each medical school to put its own
distinctive 'stamp' on its training.
The emphasis is on a core curriculum of factual
teaching supplemented by and with equal
emphasis on special study modules:- "The
greatest educational opportunities will be
afforded by that part of the course which goes
beyondthe limitsofthe core, thatallows students
to study indepth in areasofparticular interest to
them, that provides them with insights into
scientific method and the discipline ofresearch
andthatengenders anapproach tomedicine that
is constantly questioning and self-critical".
However, without being cynical, one wonders if
all the members ofthe General Medical Council
really mean what they say. The Council goes on
to enumerate attitudinal objectives which a
training in medicine should achieve. There are
twelve in all, eachworthy, butthatrelating to the
acceptance of the responsibility to contribute to
the advancement ofmedical knowledge is listed
last-letushopethatheavenly influences operate
here and the last indeed shall be first.
Ourlimitedacademicresources,however,present
us with a challenge and the new curriculum is a
potential threat to clinical research. For the best
of educational reasons it is labour-intensive for
the teachers, yet it is unreasonable and
educationally unsound to assume that all the
teachingwillbedonebythenon-research-active,
and indeed the strongest case can be made for
sufficient critical teaching mass so that the most
active researchers have the time and the support
to impart their knowledge and enthusiasm to the
next generation. This requires careful planning
sothat limitedacademicresources areusedtothe
full and, where possible, future doctors, dentists
andnursesaretaughttogetherandNationalHealth
Service doctors have sufficient time to honour
theirteachingobligations. Equally,theimportance
of non-medical scientists cannot be over-
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emphasised. Whether working in the Health
ServiceorintheUniversity, theircareerstructure
and security of tenure should be such that they
can contribute fully to the teaching programme
and to medical research and health care delivery.
This latter group is particularly important in
intercalated BSc degrees and in combined MB/
PhD programmes where the medically qualified
obtain the fundamentals of other branches of
science which they can then apply in their future
career. These intercalated degrees have been
shownin several studies tobethekey elements in
the future careers of many leaders of academic
medicine and of clinical researchers. The
undergraduate curriculum therefore cannot be
looked atin isolationbutforms acontinuumwith
postgraduate medical training and impinges on
the training of other professionals involved in
health care delivery. It must be emphasised that
allmedicalpractitioners shouldhavethecapability
to play their part in the sciences ofclinical audit,
research on outcomes, and use of information
systems.
Some of these skills will be attained in the
undergraduatecurriculum,butitwillbenecessary
to continue at a postgraduate level, perhaps with
the attainment of a Master's degree in research
methodology.
For the few, aspiring to be academic leaders and
clinician scientists, a more flexible training
programme is essential, with three/four years set
aside to learn laboratory or statistical and
epidemiological skills. It is the need for this
carefullyplannedprogrammewhichposes oneof
the major threats to the survival of the clinician
scientist. The difficulties of planning such a
programme, taking into account the Calman
recommendations for postgraduate medical
training, andtheevengreaterdifficultyoffunding
such a programme in the present atmosphere of
uncertainty, both academic and NHS, present us
with a major challenge. The Medical Committee
oftheHigherEducation & Funding Councils has
noted a fall in the number of applicants for
academic posts and the House of Lords Select
Committee on Science and Technology in its
recent report "Supporting Research and
Development in the NHS", alerts us further to
this danger.
Lord Walton and his committee state:- "The
evidencethatanincreasing numberofdoctors are
choosing a career in clinical practice rather than
academic medicine is very powerful".'2 The
Committee go on to ask that the government
shouldgiveurgentprioritytothisproblem sothat
theissuecanbeanalysedandappropriateremedies
implemented. What about other resources
essential to clinical science? The NHS has been
described as the largest and potentially the best
human biology laboratory in the world. This is
probably true, but as with all large organisations,
the prioritisation for the use ofresources and the
measurement of effectiveness of that use is
difficult, and several general points have to be
made. First, it is government that determines
research expenditure and for all governments
expenditure in biomedical research is in
competition with expenditure on other branches
ofscience, someofwhichmayhavemorepolitical
oreconomicshort-termbenefit. Mostgovernments
have in the last few decades maintained absolute
levels of expenditure for medical research but
havenotmanagedtomaintainrelative values; for
example, only recently have defence research
budgets been cut, andmoreovermanypoliticians
seem unaware of the financial benefits which
have resulted from medical research.
Would that the public, who are perhaps more
intelligent than some ofourpoliticians, know for
example that to take some statistics from the
United States:-'3
* The introduction of lithium for the treatment
of Manic Depression has saved 145 billion
dollars in hospitalisation costs in 25 years.
* Potassium citrate treatment for preventing
kidney stone recurrence saves an estimated
400-870 million dollars per year.
* The haemophilus influenza B vaccine for
meningitis a further 350-450 million dollars
annually.
* ThedisputedandexpensiveInterferontherapy
recently on trial for multiple sclerosis has
reduced hospitalisation by 25%.
In addition new rational therapies are on the
horizon for Alzheimer's disease which will give
not only many millions a new lease of life, but
unfortunately may mean that certain world
statesmen will be in office even longer!
Howsadthen, thatfundingforresearchisproving
increasingly more difficult to obtain and that
only 25%o of National Institutes of Health and
20% ofMedical Research Council's alpha-rated
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projects receive funding. This is particularly
detrimental at atime when these funds have to be
spread even more thinly, including not only
traditional clinical science, but Health Services
research. It is therefore imperative that in
welcoming and implementing the Culyer report
onresearchintheHealthService,'4thegovernment
recognises that while the principles enunciated
by Culyer are rational, the resource required for
proper implementation is probably greater than
that presently available. Let us hope that these
issues are of sufficient importance to the
enfranchised of this country that they are
addressed in the various party political
manifestoes before the next general election.
But what of Northern Ireland with its medical
schoolandteachinghospitals?Muchhaschanged
in my view to modify the opinion expressed by
SirPeterFroggattand ProfessorBarryBridges in
their history of the first 150 years of the Belfast
Medical School,15 when they state that research,
whilenotwanting, was neveraprominentfeature
of this medical school.
Sir Peter and Professor Bridges emphasise that
their views are largely based on achievements
before 1948, and that the advent of the National
Health Service and the development offull-time
academic units have had a significant beneficial
effectonresearch output. Ourdistinctivecultural
characteristics, summarised as a social cohesion
despite political differences, with pragmatism
and sound clinical orientation, together with our
pridein learning, giveusafirmbasis, building on
the developments ofthe last 50 years, to become
a major medical research centre.
Iwouldliketoconsidertheseopportunities under
three headings - Regional planning, Regional
collaborations and Critical research mass. First
of all let us consider regional planning. It is
encouraging that in Northern Ireland as in other
partsoftheUnitedKingdom someframeworkfor
research has been laid down. The Universities,
stimulated in part by the funding council's
Research Assessment Exercise, have formulated
their individual research strategies, and the
DepartmentofHealthhas morerecently begun to
define its research priorities. Nationally, efforts
are being made to maximise on resource and to
prevent the divergence of medical school and
Health Service priorities. How much more
importantthatwe, in a smallregion of 1.6 million
people shouldachievethisobjective. Itistherefore
encouraging that at last there appears to be some
movement on the appointment of a Regional
Director for research and development. Given
the advantage that we can learn from others'
mistakes, let us hope that we can formulate a
structure which embraces biomedical research
for the province and thus enables all players to
achieve maximum output.
Weexpectand indeedhopethattheCulyerreport
will be implemented in Northern Ireland and it is
therefore important that this Hospital defines its
core research facilities and is ready to benefit
fromthe national competition. Howencouraging
therefore that the Trust Board has decided to
increasefurtherourresearchprofilebyadvertising
foraClinicalResearchFellowatconsultantlevel.
Secondly what ofthe very fruitful collaborations
we can develop to further our research? These
clearly range from the local to the national and
international, and again should be focused,
strengthening our mainstreams of research but
not stifling individual curiosity. Indeed it is this
very process of focusing, by which a research
culture is achieved, which stimulates the
individual and leads to a response with new and
original ideas. Many schemes for collaboration
existbut I would like to mention the potential for
industrial collaboration. The Northern Ireland
IndustrialResearchandTechnologyUnit(IRTU),
linked to the National Office of Science and
Technology, has long been concerned that
biomedical research has notdeveloped overall to
a significant degree in Northern Ireland, though
in some branches major success has been
achieved: the reasons for this are various and
beyond mycapability ofanalysis. Certainly ifwe
attempt to develop genetic biotechnology, we
have many highly successful competitors,
frequently based adjacent to the great graduate
institutes of the world, such as Cambridge,
England, and Cambridge, Massachussetts. How
much better that we consider some other
enterprise; for example could this Hospital,
working together with the medical school's new
Department of Telemedicine, and through the
good offices of IRTU, find an appropriate
industrial partner to exploit these new
developments in medicine? I would hope these
and other worthy examples should get serious
attention.
Finally, ourachievementofcriticalresearchmass,
and here we have particularly interesting
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opportunities. Perhaps, uniquely in Europe, we
have an intellectual continuum, within a few
square miles, of basic science, all clinical
specialties at secondary and tertiary level,
incorporating Queen'sUniversity anditsmedical
school and the major Belfast teaching hospitals:
this in a region of 1.6 million people, with a
strong primary care and community base. We
haveanexcellentinfrastructure andourobjective
must be to become the leading medical centre in
Ireland, withaplanneduseofresourcesincluding
basic science, community, and acute hospital
facilities. The latter ofcourse must be the hub of
thebiologicalresearchwheel, whilethedispersed
community services are essential for
epidemiological research. Almost certainly we
have not achieved optimum planning in these
respects and will only do so if several principles
are adhered to. First and foremost the decisions
mustbe based on science and on need, and noton
political objectives. We must request and
encourage our politicians to absolve themselves
from their parochial responsibilities, and instead
tojoinwithus in meeting the greaterchallenge of
an acute hospital plan for Northern Ireland, a
Regional Specialty plan, and a research and
development plan.
I therefore have sympathy with the constraints
placed upon the McKenna Committee and I
certainly hope that the McKenna report,'6 which
will undoubtedly be a stimulus for discussion,
will not necessarily be the final word on a
framework for specialty rationalisation. If we
continue to use a King Solomon approach to the
baby of acute medicine in Belfast, then we will
certainly lose that baby. Much more thought
needs to go into the development ofthe City and
Royal Hospitals sites, perhaps not in a
complementarystyle, butratherinaunifiedstyle,
from primary through to tertiary care. Such an
approach will take much time and furtherdebate,
but if we use the guiding principles of service
needs and of the fully-costed needs of teaching
andresearch, then the rewards will benefit us all.
So back to you students. Your opportunities too
areenormousandyoucanlooktoamostrewarding
future. You can imagine it is January 1st, 2004.
You may wellbeworking inthishospital, getting
yourwake-upcall, abitgroggy because lastnight
it was a good party, but encouraged by your
surroundings in the luxury ofthe new Royal, and
further encouraged by the dulcet tones of your
ChiefExecutive reminding you that it's 6.30 am,
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and please remember the Mission Statement. It's
New Year's day, but in this, the 21st century, all
the wards and operating theatres are open 365
days a year, so you dash off, perhaps to the Gene
Therapy Clinic or the Cognitive Therapy
Workshop. Perhaps you look at patients, notjust
fromNorthern Ireland butfromfurtherafield, for
world medicine will have to maximise use of
expensive resources.
So to all medical students I would say, take heart,
you will have a wonderful time in medicine. Do
not be too concerned about health care reforms -
they are predictable and happen about every 20
years; do not worry about curriculum reforms -
the intelligent teach themselves; honour your
teachers - they may have many deficiencies but
they are probably doing their best; and above all
- honour your patients - because they are your
scientific partners.
Finally, Iwoulddirectyourattentiontosomething
attributed to that great internationalist and
Christian humanist, Erasmus, born to an
unmarried mother and orphaned when both his
parents died ofthe plague when he was 13. "Live
as ifyou are todietomorrow, study as ifyou were
to live forever".
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